Work Location , Expected Annual Income :
Tokyo,8.0M ～ 11.0M
About the Company :
Global European Healthcare Start-Up
Responsibilities :
Responsibilities
You will:
- Prepare, conduct and reports site selection, initiation, routine monitoring and close-out visits
- Perform CRF review, source document verification and query resolution
- Be responsible for site communication and management
- Act as a communication point between project teams and the site
- Leads project team calls on a country level
- Ensure that subject recruitment targets are timely defined, communicated, recorded and met, and project timelines are followed at site level
- Participate in feasibility research
- Support regulatory team in preparing documents for study submissions
- Prepare and participate in site audits and inspections
Benefits :
Office Location: Tokyo
Working Style: Full Remote Okay!!
Employment Type: Full Time Employee
Budget: 8~11mil annual total (Dependent on experience level)
Bonus: 1 time a year
Interview Steps: 2
Reporting Language: Japanese
Health and Social Insurances: Fully Covered.
Required Experience / Abilities / Skills :
Office is located in Tokyo, Japan with Hybrid or remote work arrangement available.
Applicants outside of Tokyo are welcome to apply.
- College/University degree in Life Sciences, Pharmacy, RN or an equivalent combination of education, training & experience
- At least 3 years’ site monitoring experience at a CRA II or equivalent qualification level in Japan
- Experience in all types of monitoring visits in Phase II and/or III
- Experience in feasibility assessment and study set-up process is preferable
- Therapeutic area experience in Oncology /Hematology /Gastroenterology (IBD) /Infectious Diseases /Neurology/Renal is a plus
- Full working proficiency in Japanese and Intermediate English
- PC skills to be able to work with MS Word, Excel and PowerPoint
- Ability to plan, multitask and work in a dynamic team environment
- Communication, collaboration, and problem-solving skills
- Ability to travel up to 30% to 40%